General Biologicals

General Biologicals Current Assets

The Current Assets of General Biologicals (4117.TWO) as of Oct 31, 2026 is 64.15 M TWD. In the previous year, Current Assets was 446.61 M TWD — a change of -85.64% (lower).

Current Assets

64.15 MTWD

YoY

-85.64%

Last updated:

Current Assets of General Biologicals is 2025 64.15 M TWD. Current Assets of General Biologicals was 2024 446.61 M TWD. It decreases by -85.64% lower compared to the previous year.

The General Biologicals Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
145.77 M TWD
Jan 1, 2019
32.99 M TWD
Jan 1, 2020
608.91 M TWD
Jan 1, 2021
510.32 M TWD
Jan 1, 2022
550.97 M TWD
Jan 1, 2023
401.85 M TWD
Jan 1, 2024
446.61 M TWD
Jan 1, 2025
64.15 M TWD
The General Biologicals Current Assets history
YEARCurrent AssetsYoY
64.15 MTWD-85.64%
446.61 MTWD+11.14%
401.85 MTWD-27.07%
550.97 MTWD+7.97%
510.32 MTWD-16.19%
608.91 MTWD+1,745.74%
32.99 MTWD-77.37%
145.77 MTWD-10.56%
162.98 MTWD+32.63%
122.88 MTWD-33.93%
185.99 MTWD-32.50%
275.54 MTWD-17.39%
333.53 MTWD+197.58%
112.08 MTWD+29.57%
86.50 MTWD-31.16%
125.65 MTWD-8.18%
136.84 MTWD-8.64%
149.78 MTWD+33.98%
111.80 MTWD-20.15%
140.01 MTWD-6.29%
149.40 MTWD-0.78%
150.57 MTWD+10.64%
136.09 MTWD+9.74%
124.01 MTWD+3.78%
119.49 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

General Biologicals Stock analysis

What does General Biologicals do? General Biologicals Corp., headquartered in Baoshan, Hsinchu, Taiwan, operates in the Health Care sector, specifically within the Biotechnology industry. The company engages in research, development, manufacturing, and trading of diagnostics, pharmaceuticals, and medical supplies. Its main products include detection reagents, biological protein new drugs, P113, and medical supplies, distributed domestically and internationally. Listed on 4 July 2002, the company employs 63 people. General Biologicals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about General Biologicals stock

Current Assets of General Biologicals is 64.15 M TWD in 2025.

Current Assets of General Biologicals changed from 446.61 M TWD to 64.15 M TWD, representing a -85.64% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets General Biologicals since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's General Biologicals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — General Biologicals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — General Biologicals